• 제목/요약/키워드: DNA damage checkpoint

검색결과 33건 처리시간 0.02초

두경부 편평 세포암에서 예후인자로서의 p53 발현 (The Overexpression of p53 in Head and Neck Squamous Cell Carcinoma as Prognostic Marker)

  • 정승원;이형석;박철원;박용욱;박찬금;장세진;태경
    • 대한두경부종양학회지
    • /
    • 제17권2호
    • /
    • pp.169-173
    • /
    • 2001
  • Objectives: The p53 tumor suppressor gene encodes a nuclear transcription factor that is critical regulator of cell growth and proliferation through its action in cell-cycle checkpoint control. The wide variety of stressful stmuli which include DNA damage, hypoxia, heat shock, metabolic changes activate the p53 protein, which in turn drives a series of events that culminate either in cell cycle arrest or apoptosis. Mutations of the p53 gene is the most common genetic alteration in human cancer. This gene is altered in approximately 40-60% of head and neck cancers. Whereas the wild-type form of the p53 protein plays a central role in cell-cycle control in response to DNA damage, most of the mutant forms are unable to do so. The high levels of p53 protein expression in tissues are related to the increased cellular proliferative activity and may be associated with the poor clinical outcome. To determine whether the expression of the p53 protein has prognostic significance and is associated with patterns of treatment failure in head and neck squamous cell carcinoma (HNSCC), We analyzed p53 overexpression in 40 cases of HNSCC. Materials and Methods: Immunohistochemical analysis with a monoclonal antibody (DO7) specific for p53 protein was used to detect expression of the protein in formalin-fixed, paraffin-embedded tumor samples from 40 HNSCC. We evaluated p53 protein expression and analyzed the relationship between the p53 overexpression and age, sex, primary tumor site, stage, survival rate, recurrence. All reported P values resulted from two-sided statistical tests. Results: Overexpression of p53 was detected in 20 cases(50%) among 40 cases of HNSCC. The p53 overexpression was not associated with age, sex, primary tumor site, stage, recurrence and survival rate. Conclusions: In our results, p53 was not significant prognostic factor in HNSCC. Based on many previous studies, It is evident that p53 has a certain role in tumorigenesis of HNSCC. So, the further study is needed to evaluate the prognostic significance of p53 in HNSCC.

  • PDF

Involvement of Cdc25c in Cell Cycle Alteration of a Radioresistant Lung Cancer Cell Line Established with Fractionated Ionizing Radiation

  • Li, Jie;Yang, Chun-Xu;Mei, Zi-Jie;Chen, Jing;Zhang, Shi-Min;Sun, Shao-Xing;Zhou, Fu-Xiang;Zhou, Yun-Feng;Xie, Cong-Hua
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권10호
    • /
    • pp.5725-5730
    • /
    • 2013
  • Cancer patients often suffer from local tumor recurrence after radiation therapy. Cell cycling, an intricate sequence of events which guarantees high genomic fidelity, has been suggested to affect DNA damage responses and eventual radioresistant characteristics of cancer cells. Here, we established a radioresistant lung cancer cell line, A549R, by exposing the parental A549 cells to repeated ${\gamma}$-ray irradiation with a total dose of 60 Gy. The radiosensitivity of A549 and A549R was confirmed using colony formation assays. We then focused on examination of the cell cycle distribution between A549 and A549R and found that the proportion of cells in the radioresistant S phase increased, whereas that in the radiosensitive G1 phase decreased. When A549 and A549R cells were exposed to 4 Gy irradiation the total differences in cell cycle redistribution suggested that G2-M cell cycle arrest plays a predominant role in mediating radioresistance. In order to further explore the possible mechanisms behind the cell cycle related radioresistance, we examined the expression of Cdc25 proteins which orchestrate cell cycle transitions. The results showed that expression of Cdc25c increased accompanied by the decrease of Cdc25a and we proposed that the quantity of Cdc25c, rather than activated Cdc25c or Cdc25a, determines the radioresistance of cells.

CYC8에 의한 rad53 돌연변이의 표현형 억제에 대한 연구 (Phenotypic Suppression of Rad53 Mutation by CYC8)

  • 박경준;최도희;권성훈;김준호;배성호
    • 미생물학회지
    • /
    • 제46권2호
    • /
    • pp.122-126
    • /
    • 2010
  • RAD53은 효모의 검문지점 경로가 DNA 손상을 감지하여 여러 가지 후속적인 세포 내 반응을 일으키는 데 핵심적인 역할을 하는 인산화 효소일 뿐만 아니라, dNTP 생성에 중요한 RNR 유전자 등의 전사 활성화 과정에도 관여하는 효모의 생존에 필수적인 유전자이다. 본 연구에서는 rad53${\Delta}$ 돌연변이의 hydroxyurea에 대한 민감성을 억제하는 억제자로서 CYC8을 동정하였다. CYC8 유전자가 많은 사본으로 존재할 때 rad53${\Delta}$ 균주의 hydroxyurea에 대한 내성이 증가하였으나, CYC8과 복합체로 작용하는 TUP1은 다사본 억제자로 작용하지 못하였다. 반면, 삭제 돌연변이의 경우, cyc8${\Delta}$과 tup1${\Delta}$ 모두 억제자로 작용하였다. CYC8은 효모에서 프리온 단백질로 작용하기 때문에 과량 발현되면 정상적인 CYC8 단백질의 잘못된 접힘을 유발하게 되고, 결과적으로 우성의 $cyc8^-$ 표현형이 나타나게 된다. 따라서 CYC8이 다사본 억제자로 작용하는 이유는 이러한 프리온의 특성 때문으로 추측된다. CYC8이 다사본이거나 cyc8${\Delta}$ 돌연변이일 경우 모두 RNR 유전자의 전사가 증가되는 것을 관찰하였다. 따라서 CYC8에 의한 rad53${\Delta}$ 돌연변이의 억제는 RNR 증가에 따른 세포 내 dNTP 증가 때문으로 생각된다.